These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 750077)

  • 1. A study of the labetalol-induced changes in conductivity and refractoriness of the dog heart in situ.
    Amlie JP
    Cardiovasc Res; 1978 Nov; 12(11):646-52. PubMed ID: 750077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels and electrophysiological effects of acebutolol (M & B 17.803) in the dog heart in situ.
    Amlie JP; Lessum S; Collins RF; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):378-88. PubMed ID: 190859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The electrophysiological effects of intravenous labetalol in man.
    Harley A; Coverdale HA
    Eur J Clin Pharmacol; 1981; 20(4):241-4. PubMed ID: 7308279
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of nifedipine on the sinus and atrioventricular node of the dog heart after beta-adrenergic receptor blockade.
    Amlie JP; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1978 Apr; 42(4):287-91. PubMed ID: 26163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental electrocardiographic research. Study in the rat of the cardiovascular effects of labetalol].
    Valora N; Floridi S; Bruno C; Mei V; Pranzetti P; Cherchi GM
    Boll Soc Ital Biol Sper; 1981 May; 57(10):1089-95. PubMed ID: 7295393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol.
    Gribbin HR; Mackay AD; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1981 Jul; 12(1):61-5. PubMed ID: 6264936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acebutolol-induced changes in refractoriness and monophastic action potential of the right ventricle of the dog heart in situ.
    Amlie JP; Refsum H; Landmark K
    Cardiovasc Res; 1978 Aug; 12(8):493-6. PubMed ID: 719662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prolonged pentobarbital anaesthesia on cardiac electrophysiology and inotropy of the dog heart in situ.
    Amlie JP; Owren T
    Acta Pharmacol Toxicol (Copenh); 1979 Apr; 44(4):264-71. PubMed ID: 433620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nifedipine on the monophasic action potential and refractoriness of the right ventricle of the dog heart in situ after beta-adrenergic receptor blockade.
    Amlie JP; Refsum H; Landmark K
    Acta Pharmacol Toxicol (Copenh); 1979 Mar; 44(3):185-90. PubMed ID: 433608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ.
    Landmark K; Amlie JP
    Eur J Cardiol; 1976 Dec; 4(4):419-27. PubMed ID: 1001337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of oral labetalol on myocardial conduction after coronary artery bypass grafting.
    Reder RF; Mindich B; Halperin J; Litwak RS; Kupersmith J
    Clin Pharmacol Ther; 1984 Apr; 35(4):454-60. PubMed ID: 6608433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of propranolol, pindolol, oxprenolol and acebutolol on atrioventricular conduction in unanaesthetized dogs.
    Kantelip JP; Duchene-Marullaz P; Delaigue-Fabry R; Eschalier A
    Br J Clin Pharmacol; 1982; 13(Suppl 2):159S-166S. PubMed ID: 6125165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac electrophysiologic actions of SCH 19927 (Dilevalol), the R,R-isomer of labetalol.
    Lynch JJ; Montgomery DG; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Dec; 239(3):719-23. PubMed ID: 3795037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The electrophysiological evaluation of intravenous acebutolol, a beta-blocking drug.
    Marrott PK; Ruttley MS; Jenkins PM; Muir JR
    Eur J Cardiol; 1977 Oct; 6(2):117-30. PubMed ID: 913484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic efficacy of labetalol as assessed by programmed electrical stimulation.
    Krumpl G; Todt H; Krejcy K; Raberger G
    Br J Pharmacol; 1990 Aug; 100(4):855-61. PubMed ID: 2207504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological effects of labetalol in man.
    Richards DA
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):721-3. PubMed ID: 10949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha- and beta-adrenoceptor blocking properties of labetalol in renin release.
    Lammintausta R; Koulu M; Allonen H
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):240-43. PubMed ID: 38214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypotensive and vascular effects of labetalol in the normotensive rat and dog.
    Hashimoto K; Hashimoto T; Iizuka H; Tsukada T; Matsuda H; Imai S
    Jpn Heart J; 1978 Sep; 19(5):762-74. PubMed ID: 32409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagus- and post-acetylcholine-induced changes in ventricular electrophysiology of the dog heart with and without beta-blockade.
    Amlie JP; Refsum H
    Eur Surg Res; 1984; 16 Suppl 2():5-13. PubMed ID: 6144548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.